Global Bariatric Devices Market Size By Type (Calorie Intake, Hereditary), By Application (Bariatric Surgery Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Bariatric Devices Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.5 billion by 2031, growing at a CAGR of 9.8% during the forecast period from 2023 to 2031. This growth is driven by the global surge in obesity rates, rising awareness of weight management solutions, and increasing investments in minimally invasive bariatric procedures. Bariatric devices, which include gastric balloons, gastric bands, and electrical stimulation devices, are becoming increasingly popular alternatives to conventional weight-loss surgeries. As healthcare providers seek more cost-effective and less invasive solutions, demand for bariatric devices is expected to accelerate.

Drivers:

Rising Prevalence of Obesity:

The escalating global obesity epidemic is the primary driver of the bariatric devices market. With more than 650 million adults worldwide classified as obese, there is growing pressure on healthcare systems to provide effective weight-loss interventions.

Preference for Minimally Invasive Procedures:

Minimally invasive bariatric treatments offer faster recovery, lower risks, and reduced hospital stays compared to traditional surgeries. These benefits are increasing the adoption of gastric balloons and adjustable gastric bands.

Government Initiatives and Insurance Coverage:

Governments and healthcare organizations across various countries are initiating programs to combat obesity. An increase in insurance coverage for bariatric procedures is further fueling market growth.

Restraints:

High Cost of Bariatric Devices:

Despite the long-term cost benefits, the upfront costs of bariatric devices remain high. This acts as a barrier, especially in low- and middle-income countries with limited healthcare funding.

Risks and Side Effects:

Although considered safe, bariatric devices carry potential risks such as nausea, device migration, and digestive complications, which can hinder their widespread adoption.

Opportunity:

Technological Innovation and New Product Launches:

Continuous R&D is leading to advanced bariatric devices that are safer, more efficient, and tailored to individual patient needs. Companies investing in new product development stand to gain a competitive edge.

Expansion in Emerging Economies:

Rising awareness, increasing healthcare investments, and the growing middle-class population in Asia-Pacific and Latin America present significant untapped potential for market expansion.

Market by System Type Insights:

By system type, Gastric Balloons held the dominant market share in 2023 due to their non-surgical nature, safety profile, and high success rates. This segment is expected to maintain its lead throughout the forecast period, followed closely by the growing demand for Electrical Stimulation Devices, which are gaining traction due to their ability to modulate appetite through nerve signaling.

Market by End-Use Insights:

In terms of end-use, Hospitals emerged as the leading segment in 2023, accounting for the majority of bariatric procedures performed globally. However, the Ambulatory Surgical Centers (ASCs) segment is expected to witness the highest growth rate, propelled by the increasing number of outpatient weight-loss procedures due to cost advantages and shorter recovery times.

Market by Regional Insights:

North America led the global bariatric devices market in 2023, driven by the high obesity rates, favorable reimbursement policies, and widespread adoption of minimally invasive surgeries. The Asia-Pacific region is projected to witness the fastest growth during the forecast period, supported by rising healthcare spending, growing awareness about obesity treatments, and a surge in medical tourism.

Competitive Scenario:

Key players operating in the Global Bariatric Devices Market include:

Medtronic plc

Apollo Endosurgery Inc.

Johnson & Johnson (Ethicon)

ReShape Lifesciences Inc.

Allurion Technologies

GI Dynamics Inc.

Obalon Therapeutics Inc.

These companies are focusing on mergers and acquisitions, regional expansion, and product innovation to strengthen their foothold. For instance:

In 2023, Allurion Technologies launched a next-gen swallowable gastric balloon with digital health integration.

Medtronic expanded its product portfolio with advanced electrical stimulation devices in 2024 aimed at early-stage obesity intervention.

Scope of Work – Global Bariatric Devices Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.5 billion

CAGR (2023–2031) 9.8%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising obesity prevalence, technological innovation, demand for minimally invasive procedures

Opportunities Expansion in emerging markets, new product launches

Key Market Developments:

January 2023: Johnson & Johnson’s Ethicon unit received FDA approval for its novel laparoscopic gastric band with improved safety features.

June 2024: Apollo Endosurgery announced clinical trials for a dual-function device that combines endoscopic suturing with intragastric balloon therapy.

March 2025: GI Dynamics secured funding to scale its EndoBarrier device production, targeting obesity-related Type 2 diabetes.

FAQs:

1) What is the current market size of the Global Bariatric Devices Market?

The market size stood at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Bariatric Devices Market?

The major driver is the rising prevalence of obesity and growing demand for minimally invasive weight-loss solutions.

3) Which is the largest region during the forecast period in the Global Bariatric Devices Market?

North America is the largest region, driven by high obesity rates and advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in the Global Bariatric Devices Market?

The Gastric Balloons segment held the largest share in 2023.

5) Who are the key market players in the Global Bariatric Devices Market?

Key players include Medtronic, Apollo Endosurgery, Johnson & Johnson, ReShape Lifesciences, and Allurion Technologies.